Brenda Y Pacheco, PA-C | |
80 B Veterans Blvd, Acoma, NM 87034 | |
(505) 552-5300 | |
(505) 552-5490 |
Full Name | Brenda Y Pacheco |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 17 Years |
Location | 80 B Veterans Blvd, Acoma, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992981609 | NPI | - | NPPES |
H3451 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | PA2007-0046 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of New Mexico Hospital | Albuquerque, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unm Hospital | 7618889528 | 229 |
News Archive
Mothers play a central role in honour-based crime yet this is often unrecognised by police and other agencies, potentially leaving victims at risk, new research suggests.
A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute, showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Brenda Y Pacheco, PA-C Po Box 130, San Fidel, NM 87049-0130 Ph: (505) 552-5300 | Brenda Y Pacheco, PA-C 80 B Veterans Blvd, Acoma, NM 87034 Ph: (505) 552-5300 |
News Archive
Mothers play a central role in honour-based crime yet this is often unrecognised by police and other agencies, potentially leaving victims at risk, new research suggests.
A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute, showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.
Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.
› Verified 5 days ago
Lisa R. Humphries, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 80 B Veterans Blvd, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5805 | |
Michael P Bonnet, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 B Veterans Blvd, I-40, Exit 102, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 | |
Mr. David L Miller, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 B Veterans Blvd, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5490 | |
Donita Sue Demontiney, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 B Veterans Blvd, I-40, Exit 102, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 | |
Ms. Noreen Tresa Jack-mooney, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 B Veterans Blvd, I-40, Exit 102, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 | |
Mr. Joseph W Morris, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 80 B Veterans Blvd, I-40, Exit 102, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 |